1. bookVolume 58 (2020): Issue 1 (March 2020)
Journal Details
First Published
30 Mar 2015
Publication timeframe
4 times per year
access type Open Access

Comparison between thrombophilic gene polymorphisms among high risk patients

Published Online: 03 Mar 2020
Page range: 20 - 26
Received: 31 Jul 2019
Journal Details
First Published
30 Mar 2015
Publication timeframe
4 times per year

Introduction. The purpose of this study was to compare the role of the thrombophilic variants among two groups of high risk patients with vascular disorders and recurrent pregnancy loss.

Methods. 200 patients, including 76 with thrombotic accidents and 124 with two or more idiopathic recurrent miscarriage during the first trimester, were tested for the presence of Factor V (F V) Leiden G1691A, Factor II (F II) G20210A, plasminogen activator inhibitor (PAI) 4G/5G, and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms using Real time polymerase chain reaction (RT – PCR) in the Laboratory of Medical Genetics, Varna, Bulgaria between June 2016 and May 2019. Frequencies of thrombophilic gene polymorphisms were compared among the two populations and to the expected genotype frequencies.

Results. Individuals with a history of vascular disorders had a significantly higher frequency of F V Leiden variant compared to women with recurrent miscariage. There was no statistical difference between the analyzed patients for the other three thrombophilic polymorphisms. The allelic frequencies and the expected genotype frequencies of the F V, F II and MTHFR polymorphisms were calculated according to Hardy-Weinberg equilibrium. The percentages of the homozygotes for F V and F II were higher than expected in the two groups of patients. For the MTHFR there was no difference.

Conclusion. F V Leiden remains the strongest risk factor for vascular disorders and recurrent pregnancy loss. Screening for this variant should be recommended to patients with thrombotic accidents and women with repeated miscarriage. The role of F II, PAI and MTHFR remains controversial.


1. LANE, D.A., P.M. MANNUCCI, K.A. BAUER, R.M. BERTINA, N.P. BOCHKOV, V. BOULYJNKOV, et al., Inherited thrombophilia: part 1. Thrombosis and haemostasis, 1996. 76(05): p. 651–662.Search in Google Scholar

2. BUCHHOLZ, T. and C.J. THALER, Inherited thrombophilia: impact on human reproduction. American Journal of Reproductive Immunology, 2003. 50(1): p. 20–32.Search in Google Scholar

3. CORIU, L., R. UNGUREANU, R. TALMACI, V. USCATESCU, M. CIRSTOIU, D. CORIU, et al., Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience. Journal of medicine and life, 2014. 7(4): p. 567.Search in Google Scholar

4. BERTINA, R.M., B.P. KOELEMAN, T. KOSTER, F.R. ROSENDAAL, R.J. DIRVEN, H. DE RONDE, et al., Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994. 369(6475): p. 64.Search in Google Scholar

5. RIDKER, P.M., J.P. MILETICH, C.H. HENNEKENS, and J.E. BURING, Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. Jama, 1997. 277(16): p. 1305–1307.Search in Google Scholar

6. POORT, S.R., F.R. ROSENDAAL, P.H. REITSMA, and R.M. BERTINA, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996. 88(10): p. 3698–3703.Search in Google Scholar

7. ROSENDAAL, F., C.J.M. DOGGEN, A. ZIVELIN, V. ARRUDA, M. AIACH, D. SISCOVICK, et al., Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and haemostasis, 1998. 79(04): p. 706–708.Search in Google Scholar

8. BARCELLONA, D., L. FENU, C. CAULI, G. PISU, and F. MARONGIU, Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thrombosis and haemostasis, 2003. 90(12): p. 1061–1064.Search in Google Scholar

9. WILLIAMS, K.T. and K.L. SCHALINSKE, Homocysteine metabolism and its relation to health and disease. Biofactors, 2010. 36(1): p. 19–24.Search in Google Scholar

10. DEN HEIJER, M., S. LEWINGTON, and R. CLARKE, Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. Journal of Thrombosis and Haemostasis, 2005. 3(2): p. 292–299.Search in Google Scholar

11. HICKS, L.K., H. BERING, K.R. CARSON, J. KLEINERMAN, V. KUKRETI, A. MA, et al., The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood, 2013. 122(24): p. 3879–3883.Search in Google Scholar

12. CONNORS, J.M., Thrombophilia testing and venous thrombosis. New England Journal of Medicine, 2017. 377(12): p. 1177–1187.Search in Google Scholar

13. SIMIONI, P., Who should be tested for thrombophilia? Current opinion in hematology, 2006. 13(5): p. 337–343.Search in Google Scholar

14. ANTONOV, A., Correlation between Tumor Angiogenesis, Mutation Load, Changes in the Blood Count and the Thrombogenic Risk in Patients with Essential Thrombocythaemia and Polycythaemia Vera///Корелационна зависимост между туморната ангиогенеза, мутационния товар, промените в кръвната картина, и тромбогенния риск при пациенти с есенциална тромбоцитемия и полицитемия вера. 2018, Medical University of Varna.Search in Google Scholar

15. NIKOLOVA-VLAHOVA M., SAVOV AL., BALEVA M. AND KARAGIOZOVA ZH., Hereditary thrombophilic factors and antiphospholipid syndrome. Medicinski pregled, 2019. 55(1): p. 46–52.Search in Google Scholar

16. BENDER ATIK, R., O.B. CHRISTIANSEN, J. ELSON, A.M. KOLTE, S. LEWIS, S. MIDDELDORP, et al., ESHRE guideline: recurrent pregnancy loss. 2018, Oxford University Press DOI: 10.1093/hropen/hoy004.Search in Google Scholar

17. IVANOV, P.D., R.S. KOMSA-PENKOVA, E.I. KONOVA, K.S. KOVACHEVA, M.N. SIMEONOVA, and J.D. POPOV, Association of inherited thrombophilia with embryonic and postembryonic recurrent pregnancy loss. Blood Coagulation & Fibrinolysis, 2009. 20(2): p. 134–140.Search in Google Scholar

18. GONÇALVES, R.O., L.R. FRAGA, W.V.B. SANTOS, A.F.L.D. CARVALHO, B.A.V. CERQUEIRA, M.A.C. SARNO, et al., Association between the thrombophilic polymorphisms MTHFR C677T, Factor V Leiden, and prothrombin G20210A and recurrent miscarriage in Brazilian women. 2016.Search in Google Scholar

19. SERGI, C., T. AL JISHI, and M. WALKER, Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Archives of gynecology and obstetrics, 2015. 291(3): p. 671–679.Search in Google Scholar

20. WRAMSBY, M., M. STEN-LINDER, and K. BREMME, Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertility and sterility, 2000. 74(5): p. 987–991.Search in Google Scholar

21. COULAM, C.B., D. WALLIS, J. WEINSTEIN, D.S. DASGUPTA, and R.S. JEYENDRAN, Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. American Journal of Reproductive Immunology, 2008. 60(5): p. 426–431.Search in Google Scholar

22. SIMONE, B., V. DE STEFANO, E. LEONCINI, J. ZACHO, I. MARTINELLI, J. EMMERICH, et al., Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. 2013, Springer.Search in Google Scholar

23. SILAN, F., I. MOSSE, A. GONCHAR, N. SEDLYAR, A.V. KILCHEVSKY, O. YILDIZ, et al., Comparison of the thrombophilic gene polymorphisms and recurrent pregnancy loss: Results on combined gene effect of FV Leiden, FVR2, FXIII, MTHFR (A1298C and C677T), PAI-1 4G/5G and ACE I/D genes in RPL Women from Misk/Belarus and Canakkale-Sivas/Turkey. Biomedical Genetics and Genomics, 2016. 1(4): p. 87–93.Search in Google Scholar

24. EMMERICH, J., F.R. ROSENDAAL, M. CATTANEO, M. MARGAGLIONE, V. DE STEFANO, T. CUMMING, et al., Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism. Thrombosis and haemostasis, 2001. 86(09): p. 809–816.Search in Google Scholar

25. GOODMAN, C., J. HUR, C.S. GOODMAN, R.S. JEYENDRAN, and C. COULAM, Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages? American Journal of Reproductive Immunology, 2009. 62(6): p. 365–370.Search in Google Scholar

26. SAHIN, U. and M. OZCAN, The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk. The Eurasian journal of medicine, 2017. 49(1): p. 76.Search in Google Scholar

27. KARCZEWSKI, K.J., L.C. FRANCIOLI, G. TIAO, B.B. CUMMINGS, J. ALFÖLDI, Q. WANG, et al., Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. BioRxiv, 2019: p. 531210.Search in Google Scholar

28. ZARROUK, M., S. SALIM, J. ELF, A. GOTTSÄTER, and S. ACOSTA, Testing for thrombophilia in mesenteric venous thrombosis–Retrospective original study and systematic review. Best Practice & Research Clinical Gastroenterology, 2017. 31(1): p. 39–48.Search in Google Scholar

29. HWANG, K.R., Y.M. CHOI, J.J. KIM, S.K. LEE, K.M. YANG, E.C. PAIK, et al., Methylenetetrahydrofolate reductase polymorphisms and risk of recurrent pregnancy loss: A case-control study. Journal of Korean medical science, 2017. 32(12): p. 2029–2034.Search in Google Scholar

30. ELGARI, M.M., N.A. IBRAHIM, A.R.M. MUDDATHIR, F.M. ELTOOM, and I.M. IBRAHIM, Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sciences, 2017. 12(1): p. 162–166.Search in Google Scholar

31. PETRILLI, C.M., L. HEIDEMANN, M. MACK, P. DURANCE, and V. CHOPRA, Inpatient inherited thrombophilia testing. 2016.Search in Google Scholar

32. ADLER, G., E. MAHMUTBEGOVIC, A. VALJEVAC, M.A. ADLER, N. MAHMUTBEGOVIC, K. SAFRANOW, et al., Association between-675 ID, 4G/5G PAI-1 gene polymorphism and pregnancy loss: A systematic review. Acta Informatica Medica, 2018. 26(3): p. 156.Search in Google Scholar

33. MIDDELDORP, S., Inherited thrombophilia: a double-edged sword. ASH Education Program Book, 2016. 2016(1): p. 1–9.Search in Google Scholar

34. KUDO, M., H.L. LEE, I.A. YANG, and P.J. MASEL, Utility of thrombophilia testing in patients with venous thrombo-embolism. Journal of thoracic disease, 2016. 8(12): p. 3697.Search in Google Scholar

35. ZÖLLER, B., O. MELANDER, P.J. SVENSSON, and G. ENGSTRÖM, Factor V Leiden paradox in a middle-aged Swedish population: A prospective study. Vascular Medicine, 2018. 23(1): p. 52–59.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo